Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. ScripsAmerica Inc (SCRC) Message Board

ScripsAmerica Provides Highlights of Upcoming Pres

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 7769
Posted On: 03/18/2015 8:10:11 AM
Avatar
Posted By: Tutter18
ScripsAmerica Provides Highlights of Upcoming Presentation

Will Report Preliminary Fiscal 2014 Revenues of over $31 Million and Profitable Second Half of Year
Now Projecting First Quarter 2015 Net Income of over $400,000 on Revenues of more than $9.5 Million

TYSONS CORNER, Va.--(BUSINESS WIRE)--March 18, 2015--

ScripsAmerica, Inc. (OTCBB: SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today provided the investment community highlights of comments it will be making at the Wall Street Analyst Forum's 25th Annual Institutional Investor Conference about the Company's significantly improved financial results, outstanding growth of the specialty pharmacy business and rapid emergence of new revenue streams from diabetic medical supplies, PIMD International, Inc. and physician dispensing programs. This conference will be held at the University Club in New York, NY on Thursday, March 19, 2015.

-- The Company is currently projecting first quarter 2015 Net Income of over

$400,000 on revenue of over $9.5 million

-- The Company's preliminary financial reports indicate that revenue for the

year ended December 31, 2014 is expected to exceed $31 million

-- The Company's preliminary financial reports indicate that the Company

expects to report positive Net Income and EPS for the second half of 2014

-- As of December 31, 2014, it is anticipated that the Company will have

over $1.3 million in working capital, an approximately $3 million

improvement in liquidity over the course of fiscal 2104. In addition, the

Company has a $4 million working capital line of credit, providing all of

the liquidity and capital needed to execute its 2015 growth plan

-- The Company's PIMD International subsidiary has increased revenues from

$150,000 in January to $500,000 in February, with expectations that

revenues will remain at, if not exceed, February levels for the balance

of the year

-- The Company's newly launched diabetic medical supplies business has

enrolled over 700 patients, which will ramp a valuable new revenue stream

over the balance of the year

-- The Company has signed 2 Letters of Intent to purchase additional

pharmacies, which will supplement the revenues being generated by Main

Avenue Pharmacy

Mr. Schneiderman said, "Our goal is to generate value for our shareholders and the outstanding financial performance achieved in fiscal 2014, especially over the second half of the year, has created tremendous momentum heading into 2015, with current projections of a profitable first quarter of 2015. We have put in place a strategy that capitalizes on unique market niches where ScripsAmerica has a competitive advantage, and have built the infrastructure and management team that can effectively execute a plan to grow in these markets. While there will always be headwinds, because of our increasing financial strength and diverse product offerings, we are confident that ScripsAmerica will generate attractive growth in fiscal 2015 with significant improvement to the bottom line."

A live webcast of the Company's presentation at the Wall Street Analyst Forum's Institutional Investor Conference can be accessed from ScripsAmerica's website at: www.ScripsAmerica.com.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

CONTACT: Gregory FCA

Joe Hassett, 610-228-2110

joeh@gregoryfca.com

SOURCE: ScripsAmerica, Inc.

Copyright Business Wire 2015

(END) Dow Jones Newswires

March 18, 2015 08:00 ET (12:00 GMT)


(0)
(0)




ScripsAmerica Inc (SCRC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us